Dependence on host cell cycle for activation of human immunodeficiency virus type 1 gene expression from latency

Journal of General Virology

Volumn 79, Issue 6, 1998, Pages 1363-1371

  Tobiume, Minoru ^a,b   Fujinaga, Koh ^a   Kameoka, Masanori ^a   Kimura, Takuro ^a   Nakaya, Takaaki ^a   Yamada, Takeshi ^b   Ikuta, Kazuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE G2 PHASE; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS GENE;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031835812     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-6-1363     Document Type: Article

References (53)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A. & Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of Virology 59, 284-291.
2. Baeuerle, P. A. & Baltimore, D. (1996). NF-κB: ten years after. Cell 87, 13-20.
3. Bagasra, O., Seshamma, T., Oakes, J. W. & Pomerantz, R. J. (1993). High percentages of CD4-positive lymphocytes harbor the HIV-1 provirus in the blood of certain infected individuals. AIDS 7, 1419-1425.
4. 1 transition in mouse fibroblasts. Molecular and Cellular Biology 11, 4943-4951.
5. Bednarik, D. P. & Folks, T. M. (1992). Mechanisms of HIV-1 latency. AIDS 6, 3-16.
6. Biswas, D. K., Salas, T. R., Wang, F., Ahlers, C. M., Dezube, B. J. & Pardee, A. B. (1995). A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. Journal of Virology 69, 7437-7444.
7. Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P. & Stevenson, M. (1991). Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
8. Butera, S. T., Roberts, B. D., Lam, L., Hodge, T. & Folks, T. M. (1994). Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. Journal of Virology 68, 2726-2730.
9. Cao, Y., Ho, D. D., Todd, J., Kokka, R., Urdea, M., Lifson, J. D., Piatak, M., Jr, Chen, S., Hahn, B. H., Saag, M. S. & Shaw, G. M. (1995). Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Research and Human Retroviruses 11, 353-361.
10. Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., Kuo, Y.-H., Brookmeyer, R., Zeiger, M. A., Barditch-Crovo, P. & Siliciano, R. F. (1997 a). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188.
11. Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A. & Fauci, A. S. (1997 b). Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proceedings of the National Academy of Sciences, USA 94, 13193-13197.
12. Cotner, T., Williams, J. M., Christenson, L., Shapiro, H. M., Strom, T. B. & Strominger, J. (1983). Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. Journal of Experimental Medicine 157, 461-472.
13. Cullen, B. R. (1991). Regulation of human immunodeficiency virus replication. Annual Review of Microbiology 45, 219-250.
14. Duckett, C. S., Perkins, N. D., Leung, K., Agranoff, A. B. & Nabel, G. J. (1995). Cytokine induction of nuclear factor κB in cycling and growth-arrested cells: evidence for cell cycle-independent activation. Journal of Biological Chemistry 270, 18836-18840.
15. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K. & Haase, A. T. (1993). Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362.
16. Emiliani, S., Van Lint, C., Fischle, W., Paras, P., Jr, Ott, M., Brady, J. & Verdin, E. (1996). A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proceedings of the National Academy of Sciences, USA 93, 6377-6381.
17. Evans, R. B., Gottlieb, P. D. & Bose, H. R., Jr (1993). Identification of a Rel-related protein in the nucleus during the S phase of the cell cycle. Molecular and Cellular Biology 13, 6147-6156.
18. Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A. & Fauci, A. S. (1987). Cytokine induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238, 800-802.
19. Fujinaga, K., Zhong, Q., Nakaya, T., Kameoka, M., Meguro, T., Yamada, K. & Ikuta, K. (1995). Extracellular Nef protein regulates productive HIV-1 infection from latency. Journal of Immunology 155, 5289-5298.
20. Gaynor, R. (1992). Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6, 347-363.
21. Griffin, G. E., Leung, K., Folks, T. M., Kunkel, S. & Nabel, G. J. (1989). Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature 339, 70-73.
22. Heller, R. A. & Krönke, M. (1994). Tumor necrosis factor receptor-mediated signaling pathways. Journal of Cell Biology 126, 5-9.
23. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
24. Ikuta, K., Morita, C., Miyake, S., Ito, T., Okabayashi, M., Sano, K., Nakai, M., Hirai, K. & Kato, S. (1989). Expression of human immunodeficiency virus type 1 (HIV-1) Gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens. Virology 170, 408-417.
25. Jones, K. A. & Peterlin, B. M. (1994). Control of RNA initiation and elongation at the HIV-1 promoter. Annual Review of Biochemistry 63, 717-743.
26. Kameoka, M., Kimura, T., Okada, Y., Nakaya, T., Kishi, M. & Ikuta, K. (1995). High susceptibility of U937-derived subclones to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation. Immunopharmacology 30, 89-101.
27. Kameoka, M., Kimura, T., Zheng, Y.-H., Suzuki, S., Fujinaga, K., Luftig, R. B. & Ikuta, K. (1997). Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells. Journal of Clinical Microbiology 35, 41-47.
28. Kishi, M., Nishino, Y., Ohki, K., Kimura, T. & Ikuta, K. (1993). Persistently human immunodeficiency virus type 1-infected T cell clone expressing only doubly spliced mRNA exhibits reduced cell surface CD4 expression. Japanese Journal of Cancer Research 84, 153-162.
29. Kolesnick, R. & Golde, D. W. (1994). The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77, 325-328.
30. Li, G., Simm, M., Potash, M. J. & Volsky, D. J. (1993). Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. Journal of Virology 67, 3969-3977.
31. Lint, C.V., Emiliani, S., Ott, M. & Verdin, E. (1996). Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO Journal 15, 1112-1120.
32. McCune, J. M. (1995). Viral latency in HIV disease. Cell 82, 183-188.
33. Meichle, A., Schütze, S., Hensel, G., Brunsing, D. & Krönke, M. (1990). Protein kinase C-independent activation of nuclear factor κB by tumor necrosis factor. Journal of Biological Chemistry 265, 8339-8343.
34. Michael, N. L., Mo, T., Merzouki, A., O'Shaughnessy, M., Oster, C., Burke, D. S., Redfield, R. R., Birx, D. L. & Cassol, S. A. (1995). Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. Journal of Virology 69, 1868-1877.
35. Nabel, G. J. (1993). The role of cellular transcription factors in the regulation of human immunodeficiency virus gene expression. In Human Retroviruses, pp. 46-73. Edited by B. R. Cullen. Oxford: IRL Press.
36. Nabel, G. & Baltimore, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
37. Okada, Y., Kimura, T., Kameoka, M., Kishi, M., Azuma, I. & Ikuta, K. (1995). Viral activation from latency during retrodifferentiation of U937 cells exposed to phorbol ester followed by infection with human immunodeficiency virus type 1. Immunopharmacology 30, 27-39.
38. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P. & Fauci, A. S. (1993). HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358.
39. Patterson, B. K., Till, M., Otto, P., Goolsby, C., Furtado, M. R., McBride, L. J. & Wolinsky, S. M. (1993). Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260, 976-979.
40. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
41. Perelson, A. S., Essunger, P., Cao, Y., Vasenen, M., Hurley, A., Saksela, K., Markowitz, M. & Ho, D. D. (1997). Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191.
42. Piatak, M., Jr, Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K. C., Hahn, B. H., Shaw, G. M. & Lifson, J. D. (1993). High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749-1754.
43. Pomerantz, R. J., Trono, D., Feinberg, M. B. & Baltimore, D. (1990). Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61, 1271-1276.
44. Pomerantz, R. J., Bagasra, O. & Baltimore, D. (1992a). Cellular latency of human immunodeficiency virus type 1. Current Opinion in Immunology 4, 475-480.
45. Pomerantz, R., Seshamma, T. & Trono, D. (1992b). Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency. Journal of Virology 66, 1809-1813.
46. Schreck, R., Rieber, P. & Baeuerle, P.A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO Journal 10, 2247-2258.
47. Schreiber, E., Matthias, P., Muller, M. M. & Schaffner, W. (1989). Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Research 17, 6419.
48. Schuitemaker, H., Kootstra, N. A., Fouchier, R. A. M., Hooibrink, B. & Miedema, F. (1994). Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity. EMBO Journal 13, 5929-5936.
49. Spina, C. A., Guatelli, J. C. & Richman, D. D. (1995). Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. Journal of Virology 69, 2977-2988.
50. Takai, A., Ogawara, M., Tomono, Y., Imajoh-Ohmi, S., Tsutsumi, O., Taketani, Y. & Inagaki, M. (1996). Mitosis-specific phosphorylation of vimentin by protein kinase C coupled with reorganization of intracellular membranes. Journal of Cell Biology 133, 141-149.
51. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, H. H., Saag, M. S. & Shaw, G. M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
52. Weinberg, J. B., Matthews, T. J., Cullen, B. R. & Malim, M. H. (1991). Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. Journal of Experimental Medicine 174, 1477-1482.
53. Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A. & Chen, I. S. Y. (1990). HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222.